Amicus Therapeutics Announces First Quarter 2019 Financial Results and Corporate Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to Amicus Therapeutics Announces First Quarter 2019 Financial Results and Corporate Updates

Amicus Therapeutics (FOLD) Misses Q1 EPS by 25c

May 8, 2019 7:23 AM EDT

Amicus Therapeutics (NASDAQ: FOLD) reported Q1 EPS of ($0.56), $0.25 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $34 million versus the consensus estimate of $37.86 million.

GUIDANCE:

2019 Financial Guidance

For the full-year 2019 the Company anticipates total Galafold... More